Loading clinical trials...
Loading clinical trials...
The purpose of this study is to see how the body and the cancer react to carfilzomib, including measuring the amount of the study drug in the blood at certain times following dosing. This study is bei...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Amgen
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more
NCT07224763 · ESRD (End-Stage Renal Disease), Kidney Transplantation, and more
NCT06952478 · Refractory or Relapsed Multiple Myeloma
NCT07033260 · Intradialytic Hypotension, End-Stage Renal Disease Requiring Haemodialysis, and more
Karmanos Cancer Institute
Detroit, Michigan
North Shore-LIJ Health System/Center for Advanced Medicine - North Shore University Hospital
Lake Success, New York
Gabrail Cancer Center
Canton, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions